November 16, 2023
Alzheimer's
Research
This week, Nature News highlighted AI approaches that work to better identify Alzheimer's Disease. One of these was from our article titled, "Identifying Individuals with Non-Alzheimer's Disease Co-Pathologies: A Precision Medicine Approach to Clinical Trials in Sporadic Alzheimer's Disease", wherein researchers developed a tool to ascribe the presence of non-Alzheimer's neuropathologies that contribute to the progression of this neurodegenerative disease.
October 6, 2023
Alzheimer's
PET
Research
In a significant collaborative effort between researchers and Siemens, the Medical Imaging Informatics and Artificial Intelligence center has unveiled a novel approach to understanding Alzheimer's disease (AD) progression. Their recently published paper titled "Profiling and Predicting Distinct Tau Progression Patterns: An Unsupervised Data-Driven Approach to Flortaucipir Positron Emission Tomography" sheds light on a pioneering technique that could reshape AD clinical trials and patient care.
March 6, 2023
Alzheimer's
Clinical diagnosis of Alzheimer’s disease (AD) is through a comprehensive cognitive testing, assessment of medical and family history, and symptom tracking. The true diagnosis of Alzheimer’s disease is actually done at autopsy.
March 1, 2023
Alzheimer's
Early detection of slow-progressing, long-term diseases such as Alzheimer’s (AD) is preferred among all involved – patients, caregivers, clinicians, and physicians alike.
October 1, 2022
Research
Worldwide, hundreds of millions of people spanning adulthood are afflicted with Major Depressive Disorder (MDD), and diagnosed cases have increased in recent years.
January 18, 2022
PET
Imaging with positron emission tomography (PET) has become important in diagnosing neurodegenerative diseases.
January 17, 2022
Alzheimer's
PET
Connected in vivo tau positron emission topography (PET) Magnetic Resonance Imaging (MRI) with a deep learning process that can accurately measure early Alzheimer’s Disease pathology
June 1, 2021
PET
Reduced CBF of the brain tissue is a common pathological alteration in Alzheimer’s disease (AD).
May 1, 2020
Research
Radiologist expertise is in high demand, and the queue for quality interpretation is consistently packed.
November 29, 2016
Parkinson
Michael J Fox Foundation named the winners of the 2016 Parkinson's Progression Markers Initiative Data Challenge (PPMI).
